SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
SEC Accession No. 0001144204-16-108589
Filing Date
2016-06-16
Accepted
2016-06-16 17:25:53
Documents
43
Period of Report
2016-03-31
Filing Date Changed
2016-06-16

Document Format Files

Seq Description Document Type Size
1 10-Q v442195_10q.htm 10-Q 196733
2 EXHIBIT 31.1 v442195_ex31-1.htm EX-31.1 9843
3 EXHIBIT 31.2 v442195_ex31-2.htm EX-31.2 9972
4 EXHIBIT 32.1 v442195_ex32-1.htm EX-32.1 5049
5 EXHIBIT 32.2 v442195_ex32-2.htm EX-32.2 4822
  Complete submission text file 0001144204-16-108589.txt   1873957

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT mbrx-20160331.xml EX-101.INS 278686
7 XBRL TAXONOMY EXTENSION SCHEMA mbrx-20160331.xsd EX-101.SCH 32963
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mbrx-20160331_cal.xml EX-101.CAL 16212
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mbrx-20160331_def.xml EX-101.DEF 149388
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE mbrx-20160331_lab.xml EX-101.LAB 182124
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mbrx-20160331_pre.xml EX-101.PRE 171315
Mailing Address 2575 WEST BELLFORT SUITE 333 HOUSTON TX 77054
Business Address 2575 WEST BELLFORT SUITE 333 HOUSTON TX 77054 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

IRS No.: 474671999 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37758 | Film No.: 161718335
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1